About the Authors
- Xue Cai
-
Affiliation Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
- Zack Nash
-
Affiliation Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
- Shannon M. Conley
-
Affiliation Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
- Steven J. Fliesler
-
Current address: Research Service, Veterans Administration Western New York Healthcare System, and Departments of Ophthalmology (Ross Eye Institute) and Biochemistry, SUNY-University at Buffalo, Buffalo, New York, United States of America
Affiliation Departments of Ophthalmology and Pharmacological & Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America
- Mark J. Cooper
-
Affiliation Copernicus Therapeutics, Inc., Cleveland, Ohio, United States of America
- Muna I. Naash
-
* E-mail: muna-naash@ouhsc.edu
Affiliation Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
Competing Interests
Mark J. Cooper is an employee of Copernicus Therapuetics and owns stock in the company.
Author Contributions
Conceived and designed the experiments: XC MIN. Performed the experiments: XC SMC. Analyzed the data: XC SMC SJF MJC MIN. Contributed reagents/materials/analysis tools: XC ZN SMC SJF MJC. Wrote the paper: XC SMC SJF MJC MIN.